Orrell-Valente Joan K, Jarlsberg Leah G, Rait Michelle A, Thyne Shannon M, Rubash Tabitha, Cabana Michael D
Department of Pediatrics, University of California. San Francisco, CA, USA.
J Asthma. 2007 Jun;44(5):385-90. doi: 10.1080/02770900701364221.
Specific concerns from 706 parents regarding their children's (M age = 8.0, SD = 3.9) use of daily asthma medications were systematically identified and organized. 270 (38.2%) of 706 parents expressed a total of 470 concerns (M = 1.74, SD = 0.93; Range 1-5), including concerns about side effects (48.9%; e.g., growth retardation); aspects of the regimen (29.3%; e.g., medication amount); and "steroid" use (10.4%). Independent predictors of parental concern included use of inhaled corticosteroids (OR = 1.60, 95% CI 1.07-2.40), nasal corticosteroids (OR = 1.70, 95% CI 1.21-2.38), and alternative therapies (OR = 1.84, 95% CI 1.32-2.56). Providers should be prepared to address a wide range of medication concerns, especially those related to side effects.
系统地识别并整理了706名家长对其子女(平均年龄=8.0岁,标准差=3.9)日常哮喘药物使用情况的具体担忧。706名家长中有270名(38.2%)表达了总共470项担忧(平均=1.74,标准差=0.93;范围1-5),包括对副作用的担忧(48.9%;例如生长发育迟缓);治疗方案的各个方面(29.3%;例如药物剂量);以及“类固醇”的使用(10.4%)。家长担忧的独立预测因素包括吸入性糖皮质激素的使用(比值比=1.60,95%置信区间1.07-2.40)、鼻用糖皮质激素(比值比=1.70,95%置信区间1.21-2.38)和替代疗法(比值比=1.84,95%置信区间1.32-2.56)。医疗服务提供者应准备好应对各种药物相关担忧,尤其是与副作用有关的担忧。